Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal

British Journal of Pharmacology

Volumn 140, Issue 2, 2003, Pages 295-304

  Trang, Tuan ^a   Sutak, Maaja ^a   Quirion, Remi ^b   Jhamandas, Khem ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Lipoxygenase; Opioid physical dependence; Opioid withdrawal

Indexed keywords

BAICALEIN; CALCITONIN GENE RELATED PEPTIDE; DOCEBENONE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MORPHINE SULFATE; NALOXONE; NEUROPEPTIDE; NORDIHYDROGUAIARETIC ACID; PROTEIN FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROCHEMISTRY; NONHUMAN; OPIATE ADDICTION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROVOCATION TEST; RAT; SPINAL CORD DORSAL HORN; WITHDRAWAL SYNDROME;

ANIMALS; BENZOQUINONES; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FLAVONOIDS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SPINAL; LIPOXYGENASE INHIBITORS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NORDIHYDROGUAIARETIC ACID; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0141888486     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705440     Document Type: Article

References (57)

1. ABBADIE, C., HONORE, P., FOURNIE-ZALUSKI, M.C., ROQUES, B.P. & BESSON, J.M. (1994). Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation. Eur. J. Pharmacol, 258, 215-227.
2. BENO, D.W., MULLEN, J. & DAVIS, B.H. (1995). Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr. Am. J. Physiol., 268, C604-C610.
3. CAPASSO, A. (1999). Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues. Neuropharmacology, 38, 871-877.
4. CARLTON, S.M., WESTLUND, K.N., ZHANG, D.X., SORKIN, L.S. & WILLIS, W.D. (1990). Calcitonin gene-related peptide containing primary afferent fibers synapse on primate spinothalamic tract cells. Neurosci. Lett., 109, 76-81.
5. CHIENG, B., KEAY, K.A. & CHRISTIE, M.J. (1995). Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci. Lett., 183, 79-82.
6. CONRATH, M., TAQUET, H., POHL, M. & CARAYON, A. (1989). Immunocytochemical evidence for calcitonin gene-related peptide-like neurons in the dorsal horn and lateral spinal nucleus of the rat cervical spinal cord. J. Chem. Neuroanat., 2, 335-347.
7. DENNIS, T., FOURNIER, A., CADIEUX, A., POMERLEAU, F., JOLICOEUR, F.B., ST PIERRE, S. & QUIRION, R. (1990). hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther., 254, 123-128.
8. DUNBAR, S. & YAKSH, T.L. (1996). Effect of spinal infusion of L-NAME, a nitric oxide-synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Neurosci. Lett., 207, 33-36.
9. DUNBAR, S.A., KARAMOV, I.G. & BUERKLE, H. (2000). The effect of spinal ibuprofen on opioid withdrawal in the rat. Anesth. Analg., 91, 417-422.
10. GESTREAU, C., LE GUEN, S. & BESSON, J.M. (2000). Is there tonic activity in the endogenous opioid systems?. A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide. J. Comp. Neurol., 427, 285-301.
11. GIBSON, S.J., POLAK, J.M., BLOOM, S.R., SABATE, I.M., MULDERRY, P.M., GHATEI, M.A., MCGREGOR, G.P., MORRISON, J.F., KELLY, J.S. & EVANS, R.M. (1984). Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J. Neurosci., 4, 3101-3111.
12. GILROY, D.W., TOMLINSON, A. & WILLOUGHBY, D.A. (1998). Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur. J. Pharmacol., 355, 211-217.
13. GOK, S., ONAL, A., CINAR, M.G. & EVINC, A. (1999). The antinociceptive effect of leukotriene D(4) receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism. Eur. J. Pharmacol., 386, 195-200.
14. HARISH, O.E. & POO, M.M. (1992). Retrograde modulation at developing neuromuscular synapses: involvement of G protein and arachidonic acid cascade. Neuron, 9, 1201-1209.
15. HASS, R., BRACK, M., KHARBANDA, S., GIESE, G., TRAUB, P. & KUFE, D. (1991). Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1). J. Cell Physiol., 149, 125-131.
16. HUA, X.Y., CHEN, P., MARSALA, M. & YAKSH, T.L. (1999). Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience, 89, 525-534.
17. JHAMANDAS, J.H., HARRIS, K.H., PETROV, T., YANG, H.Y. & JHAMANDAS, K.H. (1998). Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal. J. Comp. Neurol., 402, 210-221.
18. JHAMANDAS, K.H., MARSALA, M., IBUKI, T. & YAKSH, T.L. (1996). Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci., 16, 2758-2766.
19. KAWAJIRI, H., ZHUANG, D., QIAO, N., YOSHIMOTO, T., YAMAMOTO, M., ISEKI, S. & HAMAGUCHI, K. (2000). Expression of arachidonate 12-lipoxygenase in rat tissues: a possible role in glucagon secretion. J. Histochem. Cytochem., 48, 1411-1419.
20. KIRCHNER, T., APARICIO, B., ARGENTIERI, D.C., LAU, C.Y. & RITCHIE, D.M. (1997). Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation. Prostagland. Leukot. Essent. Fatty Acids, 56, 417-423.
21. LANE-LADD, S.B., PINEDA, J., BOUNDY, V.A., PFEUFFER, T., KRUPINSKI, J., AGHAJANIAN, G.K. & NESTLER, E.J. (1997). CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci., 17, 7890-7901.
22. LE GUEN, S., GESTREAU, C. & BESSON, J.M. (2001). Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis. J. Comp. Neurol., 433, 272-296.
23. LYNCH, M.A., ERRINGTON, M.L. & BLISS, T.V. (1989). Nordi-hydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: an in vivo study in the dentate gyrus of the rat. Neuroscience, 30, 693-701.
24. MA, W., ZHENG, W.H., KAR, S. & QUIRION, R. (2000). Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience, 99, 529-539.
25. MA, W., ZHENG, W.H., POWELL, K., JHAMANDAS, K.H. & QUIRION, R. (2001). Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur. J. Neurosci., 14, 1091-1104.
26. MALMBERG. A.B. & YAKSH, T.L. (1992). Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther., 263, 136-146.
27. MENARD, D.P., VAN ROSSUM, D., KAR, S., JOLICOEUR, F.B., JHAMANDAS, K. & QUIRION, R. (1995). Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. J. Pharmacol. Exp. Ther., 273, 887-894.
28. MENARD, D.P., VAN ROSSUM, D., KAR, S., ST PIERRE, S., SUTAK, M., JHAMANDAS, K. & QUIRION, R. (1996). A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J. Neurosci., 16, 2342-2351.
29. MOLANDER, C., XU, Q. & GRANT, G. (1984). The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J. Comp. Neurol., 230, 133-141.
30. MURTRA, P., SHEASBY, A.M., HUNT, S.P. & DE FELIPE, C. (2000). Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature, 405, 180-183.
31. NESTLER, E.J. (1996). Under siege: the brain on opiates. Neuron, 16, 897-900.
32. NYE, H.E. & NESTLER, E.J. (1996). Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol., 49, 636-645.
33. PEPPELENBOSCH, M.P., TERTOOLEN, L.G., DEN HERTOG, J. & DE LAAT, S.W. (1992). Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production. Cell, 69, 295-303.
34. PIOMELLI, D., SHAPIRO, E., FEINMARK, S.J. & SCHWARTZ, J.H. (1987a). Metabolites of arachidonic acid in the nervous system of Aplysia: possible mediators of synaptic modulation. J. Neurosci., 7, 3675-3686.
35. PIOMELLI, D., VOLTERRA, A., DALE, N., SIEGELBAUM, S.A., KANDEL, E.R., SCHWARTZ, J.H. & BELARDETTI, F. (1987b). Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature, 328, 38-43.
36. PITCHER, G.M. & HENRY, J.L. (1999). Mediation and modulation by eicosanoids of responses of spinal dorsal horn neurons to glutamate and substance P receptor agonists: results with indomethacin in the rat in vivo. Neuroscience, 93, 1109-1121.
37. POWELL, K.J., HOSOKAWA, A., BELL, A., SUTAK, M., MILNE, B., QUIRION, R. & JHAMANDAS, K. (1999). Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br. J. Pharmacol., 127, 631-644.
38. POWELL, K.J., MA, W., SUTAK, M., DOODS, H., QUIRION, R. & JHAMANDAS, K. (2000). Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br. J. Pharmacol., 131, 875-884.
39. PRILLER, J., HAAS, C.A., REDDINGTON, M. & KREUTZBERG, G.W. (1995). Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells. Glia, 15, 447-457.
40. PRILLER, J., HAAS, C.A., REDDINGTON, M. & KREUTZBERG, G.W. (1998a). Cultured astrocytes express functional receptors for galanin. Glia, 24, 323-328.
41. PRILLER, J., REDDINGTON, M., HAAS, C.A. & KREUTZBERG, G.W. (1998b). Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action. Neuroscience, 85, 521-525.
42. REDDINGTON, M., PRILLER, J., TREICHEL, J., HAAS, C. & KREUTZBERG, G.W. (1995). Astrocytes and microglia as potential targets for calcitonin gene related peptide in the central nervous system. Can. J. Physiol. Pharmacol., 73, 1047-1049.
43. RITCHIE, J., PITCHER, G.M. & SHARIF, R.N. (2000). Lipoxygenase inhibition depresses hyperalgesia induced by intrathecal administration of substance P, NMDA and AMPA in the rat. Soc. Neurosci. Abstr., 26, 1958.
44. ROHDE, D.S., DETWEILER, D.J. & BASBAUM, A.I. (1996). Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal (corrected). Neuroscience, 72, 233-242.
45. ROHDE, D.S., MCKAY, W.R., ABBADIE, C. & BASBAUM, A.I. (1997). Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat. Brain Res., 745, 83-95.
46. SALMON, A.M., DAMAJ, M.I., MARUBIO, L.M., EPPING-JORDAN, M.P., MERLO-PICH, E. & CHANGEUX, J.P. (2001). Altered neuro-adaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nat. Neurosci., 4, 357-358.
47. SHIMOYAMA, N., SHIMOYAMA, M., INTURRISI, C.E. & ELLIOTT, K.J. (1996). Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology, 85, 1357-1366.
48. TIE-JUN, S.S., XU, Z. & HOKFELT, T. (2001). The expression of calcitonin gene-related peptide in dorsal horn neurons of the mouse lumbar spinal cord. Neuroreport, 12, 739-743.
49. TIONG, G.K., PIERCE, T.L. & OLLEY, J.E. (1992). Sub-chronic exposure to opiates in the rat: effects on brain levels of substance P and calcitonin gene-related peptide during dependence and withdrawal. J. Neurosci. Res., 32, 569-575.
50. TRANG, T., SUTAK, M., QUIRION, R. & JHAMANDAS, K. (2002). The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br. J. Pharmacol., 136, 37-48.
51. TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87.
52. VAN ROSSUM, D., HANISCH, U.K. & QUIRION, R. (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev., 21, 649-678.
53. VASKO, M.R., CAMPBELL, W.B. & WAITE, K.J. (1994). Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci., 14, 4987-4997.
54. VAUGHAN, C.W., INGRAM, S.L., CONNOR, M.A. & CHRISTIE, M.J. (1997). How opioids inhibit GABA-mediated neurotransmission. Nature, 390, 611-614.
55. WELCH, S.P., BASS, P.P., OLSON, K.G. & PUGH, G. (1992). Morphine-induced modulation of calcitonin gene-related peptide levels. Pharmacol. Biochem. Behav., 43, 1107-1116.
56. YAKSH, T.L. & RUDY, T.A. (1976). Analgesia mediated by a direct spinal action of narcotics. Science, 192, 1357-1358.
57. YE, Z., WIMALAWANSA, S.J. & WESTLUND, K.N. (1999). Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord. Neuroscience, 92, 1389-1397.